Serum butyrylcholinesterase activity in hyperlipidaemia [4]

Atherosclerosis

Volumn 173, Issue 1, 2004, Pages 145-146

  Kálmán, János ^a   Juhász, Anna ^a   Janka, Zoltán ^a   Rakonczay, Zoltán ^a   Ábrahám, György ^a   Boda, Krisztina ^a   Farkas, Tibor ^b   Penke, Botond ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; APOLIPOPROTEIN; CHOLESTEROL; CHOLINESTERASE; PROFENAMINE; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENOTYPE; HUMAN; HYPERLIPIDEMIA; LABORATORY TEST; LETTER; MULTIINFARCT DEMENTIA; PATIENT INFORMATION; PHOTOMETRY; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 1242306271     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.002     Document Type: Letter

References (10)

1. Silver A. The Biology of Cholinesterases. North-Holland: Amsterdam; 1974.
2. Abbott C.A., Mackness M.I., Kumar S., Olukoga A.O., Gordon C., Arrol S. et al. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin. Sci. (Lond.). 85:1993;77-81.
3. Alcantara V.M., Chautard-Freire-Maia E.A., Scartezini M., Cerci M.S., Braun-Prado K., Picheth G. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scand. J. Clin. Lab. Invest. 62:2002;399-404.
4. Ellman G.L., Courtney K.D., Andre V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
5. Davies KE. Human Genetic Diseases. A Practical Approach. Oxford: IRL Press; 1986.
6. Kálmán J., Juhász A., Császár A., Kanka A., Maglóczky E., Bencsik K.et al. Apolipoprotein E allele frequencies in patients with late onset sporadic Alzheimer's dementia in Hungary. Acta Neurol. Scand. 95:1997;56-59.
7. Frenkel E.J., Roelofsen B., Brodbeck U., van Deenen L.L., Ott P. Lipid-protein interactions in human erythrocyte-membrane acetylcholinesterase. Modulation of enzyme activity by lipids. Eur. J. Biochem. 109:1980;377-382.
8. Rustemeijer C., Schouten J.A., Voerman H.J., Beynen A.C., Donker A.J., Heine R.J. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? Clin. Sci. (Lond.). 101:2001;29-35.
9. Kása P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Progr. Neurobiol. 52:1997;511-535.
10. Rakonczay Z., Kovács I. Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer therapy. Acta Biol. Hung. 49:1998;55-70.